carbogen has been researched along with Head and Neck Neoplasms in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (31.58) | 18.2507 |
| 2000's | 12 (63.16) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Jong, MA; Doornaert, PA; Janssens, GO; Kaanders, JH; Langendijk, JA; Span, PN; Takes, RP; Terhaard, CH; van den Ende, P | 1 |
| Bussink, J; de Wilde, PC; Kaanders, JH; Ljungkvist, AS; Marres, HA; Pop, LA; Raleigh, JA; van den Hoogen, FJ; van der Kogel, AJ; Wijffels, KI | 1 |
| Bussink, J; Kaanders, JH; van der Kogel, AJ | 3 |
| Amdur, RJ; Mendenhall, NP; Mendenhall, WM; Morris, CG; Siemann, DW | 1 |
| Hoogsteen, IJ; Kaanders, JH; Marres, HA; Merkx, MA; Pop, LA; van den Hoogen, FJ; van der Kogel, AJ | 1 |
| de Wilde, PC; Jonathan, RA; Kaanders, JH; Marres, HA; Merkx, MA; Oosterwijk, E; Peeters, W; van der Kogel, AJ; Wijffels, KI | 1 |
| Allal, AS; Vees, H | 1 |
| de Serdio, JL; Martinez, JC; Villar, A | 1 |
| Denekamp, J; Dennis, M; Franzén, L; Henriksson, R; Littbrand, B; Rojas, AM; Stratford, M; Zackrisson, B | 1 |
| Eschwege, F; Guichard, M; Lambin, P; Lartigau, E; Le Ridant, AM; Luboinski, B; Lusinchi, A; Martin, L; Weeger, P; Wibault, P | 1 |
| Denekamp, J; Fowler, JF | 1 |
| Denekamp, J; Dennis, MF; Dische, S; Goodchild, K; Hoskin, PJ; Pigott, K; Powell, ME; Rojas, AM; Saunders, MI; Stratford, MR | 1 |
| Bernier, J; Bieri, S; Bolla, M; Denekamp, J; Dennis, MF; Hagen, F; Kocagöncü, O; Rojas, A; Stratford, MR | 1 |
| Antognoni, P; Bernier, J; Dahl, O; Denekamp, J; Hamers, H; Horiot, J; Minatel, E; Piérart, M; Richaud, P; Rojas, A; van Glabbeke, M | 1 |
| Abdelatti, MO; Baddeley, H; Brodrick, PM; Hoskin, PJ; Jordan, LC; Phillips, H; Saunders, MI; Taylor, NJ; Vasudevan, AS | 1 |
| Artazkoz, JJ; Borque, C; Cabezon, MA; de Serdio, JL; Espiñeira, M; Fuentes, C; Gil, J; Martinez, JC; Perez, MD; Saavedra, JA; Suñer, M; Villar, A | 1 |
| Bruaset, I; Kaanders, JH; Marres, HA; Merkx, MA; Pop, LA; van den Hoogen, FJ; van der Kogel, AJ | 1 |
2 review(s) available for carbogen and Head and Neck Neoplasms
| Article | Year |
|---|---|
ARCON: a novel biology-based approach in radiotherapy.
Topics: Animals; Carbon Dioxide; Carcinoma; Cell Cycle; Cell Hypoxia; Clinical Trials as Topic; Dose Fractionation, Radiation; Head and Neck Neoplasms; Humans; Mammary Neoplasms, Animal; Mice; Niacinamide; Oxygen; Patient Selection; Radiation-Sensitizing Agents; Radiotherapy; Urinary Bladder Neoplasms | 2002 |
ARCON--current status: summary of a workshop on preclinical and clinical studies.
Topics: Animals; Carbon Dioxide; Cell Division; Cell Hypoxia; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasms; Neoplasms, Experimental; Niacinamide; Oxygen; Oxygen Consumption; Radiation-Sensitizing Agents; Radiobiology; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Regional Blood Flow; Urinary Bladder Neoplasms | 1997 |
11 trial(s) available for carbogen and Head and Neck Neoplasms
| Article | Year |
|---|---|
Quality-of-life after radiotherapy for advanced laryngeal cancer: Results of a phase III trial of the Dutch Head and Neck Society.
Topics: Adult; Aged; Aged, 80 and over; Carbon Dioxide; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Netherlands; Niacinamide; Oxygen; Quality of Life; Radiation-Sensitizing Agents; Societies, Medical; Surveys and Questionnaires | 2016 |
Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Carbon Dioxide; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma, Squamous Cell; Cell Hypoxia; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Proteins; Niacinamide; Nitroimidazoles; Oxygen; Predictive Value of Tests; Treatment Outcome | 2002 |
Radiotherapy alone or combined with carbogen breathing for squamous cell carcinoma of the head and neck: a prospective, randomized trial.
Topics: Carbon Dioxide; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Head and Neck Neoplasms; Humans; Oxygen; Radiation-Sensitizing Agents; Respiration; Survival Analysis; Time Factors | 2005 |
Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Carbon Dioxide; Carcinoma, Squamous Cell; Cell Hypoxia; Female; Head and Neck Neoplasms; Hemoglobins; Humans; Male; Middle Aged; Multivariate Analysis; Niacinamide; Oxygen; Prognosis; Radiation-Sensitizing Agents; Sex Factors; Treatment Outcome | 2006 |
Carbogen breathing combined with radical radiotherapy in advanced head and neck cancer patients with severe co-morbidities.
Topics: Aged; Aged, 80 and over; Carbon Dioxide; Carcinoma, Squamous Cell; Combined Modality Therapy; Comorbidity; Disease Progression; Dose-Response Relationship, Radiation; Feasibility Studies; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oxygen; Patient Compliance; Pilot Projects; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy Dosage; Severity of Illness Index; Survival Rate; Treatment Outcome | 2006 |
Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study.
Topics: Administration, Oral; Aerosols; Antiemetics; Carbon Dioxide; Disease-Free Survival; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Feasibility Studies; Head and Neck Neoplasms; Humans; Metoclopramide; Nausea; Niacinamide; Oxygen; Radiation-Sensitizing Agents; Radiotherapy, High-Energy; Vomiting | 1997 |
Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer.
Topics: Administration, Oral; Area Under Curve; Carbon Dioxide; Carcinoma; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Dose Fractionation, Radiation; Follow-Up Studies; Half-Life; Head and Neck Neoplasms; Humans; Lung Neoplasms; Nausea; Niacinamide; Oxygen; Pyridones; Radiation-Sensitizing Agents; Tablets; Time Factors; Treatment Outcome; Vomiting | 1998 |
ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).
Topics: Adult; Aged; Carbon Dioxide; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Head and Neck Neoplasms; Humans; Middle Aged; Niacinamide; Oxygen; Patient Compliance; Radiotherapy | 2000 |
Gas exchange parameters in radiotherapy patients during breathing of 2%, 3.5% and 5% carbogen gas mixtures.
Topics: Aged; Aged, 80 and over; Blood Gas Analysis; Carbon Dioxide; Head and Neck Neoplasms; Humans; Male; Middle Aged; Oxygen; Pelvic Neoplasms; Pulmonary Gas Exchange; Reference Standards | 2000 |
Hyperfractionated chemoradiation with carbogen breathing, with or without erythropoietin: a stepwise developed treatment schedule for advanced head-and-neck cancer.
Topics: Administration, Inhalation; Adult; Aged; Anemia; Antineoplastic Agents; Carbon Dioxide; Carboplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Erythrocyte Transfusion; Erythropoietin; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oxygen; Radiation-Sensitizing Agents; Survival Rate | 2001 |
ARCON: experience in 215 patients with advanced head-and-neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carbon Dioxide; Dose Fractionation, Radiation; Feasibility Studies; Female; Head and Neck Neoplasms; Humans; Hypoxia; Male; Middle Aged; Niacinamide; Oxygen; Radiation Injuries; Radiation-Sensitizing Agents | 2002 |
6 other study(ies) available for carbogen and Head and Neck Neoplasms
| Article | Year |
|---|---|
The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers, Tumor; Carbon Dioxide; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma, Squamous Cell; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Disease-Free Survival; Female; Glucose Transporter Type 1; Glucose Transporter Type 3; Head and Neck Neoplasms; Humans; Hypoxia; Immunohistochemistry; Male; Middle Aged; Niacinamide; Oxygen; Predictive Value of Tests; Prognosis; Radiation Dosage; Treatment Outcome | 2006 |
Chemoradiation for advanced head and neck cancer: potential for improving results to match those of current treatment modalities for early-stage tumors--long-term results of hyperfractionated chemoradiation with carbogen breathing and anemia correction wi
Topics: Administration, Inhalation; Adult; Aged; Anemia; Antineoplastic Agents; Carbon Dioxide; Carboplatin; Carcinoma, Squamous Cell; Clinical Protocols; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Erythropoietin; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oxygen; Radiation Injuries; Radiation-Sensitizing Agents; Recombinant Proteins; Salvage Therapy | 2008 |
Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome: in regard to Evans et al. (Int J Radiat Oncol Biol Phys 2007;69:1024-1031).
Topics: Carbon Dioxide; Carcinoma, Squamous Cell; Cell Hypoxia; Head and Neck Neoplasms; Humans; Nitroimidazoles; Oxygen; Prognosis; Radiation-Sensitizing Agents; Time Factors | 2008 |
Acute effects of accelerated radiotherapy in combination with carbogen breathing and nicotinamide (ARCON).
Topics: Administration, Inhalation; Aged; Carbon Dioxide; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Male; Middle Aged; Niacinamide; Oxygen; Pilot Projects; Radiation-Sensitizing Agents | 1994 |
Changes in the oxygenation of head and neck tumors during carbogen breathing.
Topics: Adult; Aged; Carbon Dioxide; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Male; Middle Aged; Oxygen; Polarography; Radiation-Sensitizing Agents | 1993 |
Clinical outcome and tumour microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide.
Topics: Carbon Dioxide; Cell Division; Cell Hypoxia; Head and Neck Neoplasms; Humans; Niacinamide; Oxygen; Radiation-Sensitizing Agents | 1999 |